Anzeige
Mehr »
Dienstag, 03.06.2025 - Börsentäglich über 12.000 News
Gestern Kursverdopplung durch Uran-Hoffnung - zündet jetzt der nächste Vervielfacher?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PUCU | ISIN: NL0014040206 | Ticker-Symbol: 39K
Hamburg
03.06.25 | 08:17
0,180 Euro
+5,88 % +0,010
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
CENTOGENE NV Chart 1 Jahr
5-Tage-Chart
CENTOGENE NV 5-Tage-Chart
RealtimeGeldBriefZeit
0,1600,36417:29

Aktuelle News zur CENTOGENE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
10.04.Research and Markets: Europe Hereditary Genetic Testing Market Research 2024-2033, Competitive Analysis of Centogene, Eurofins Scientific, and F. Hoffmann-La Roche - ResearchAndMarkets.com464The "Europe Hereditary Genetic Testing Market: Focus on Genetic Testing Type and Country Analysis and Forecast, 2024-2033" report has been added to ResearchAndMarkets.com's offering. The Europe...
► Artikel lesen
CENTOGENE Aktie jetzt für 0€ handeln
12.03.Centogene NV: CENTOGENE Closes Strategic Transaction with Private Equity Group Charme Capital Partners515CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, March 12, 2025 (GLOBE NEWSWIRE) -- Centogene N.V. (OTC: CNTGF) ("CENTOGENE" or the "Company") today announced it has closed its transaction to sell...
► Artikel lesen
10.01.Centogene N.V. - 6-K, Report of foreign issuer35
05.12.24Centogene NV: CENTOGENE Announces Voting Results of Extraordinary General Meeting419CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Centogene N.V. (OTC: CNTGF) ("CENTOGENE" or the "Company"), the essential life science partner for data-driven answers...
► Artikel lesen
05.12.24Centogene N.V. - 6-K, Report of foreign issuer4
13.11.24Centogene NV: CENTOGENE Signs Strategic Transaction With Private Equity Group Charme Capital Partners388CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Centogene N.V. (OTC: CNTGF) ("CENTOGENE" or the "Company"), the essential life science partner for data-driven answers...
► Artikel lesen
10.10.24Delisting of Securities of Gamer Pakistan Inc.; Biotricity, Inc.; Zalatoris II Acquisition Corp.; Warrantee Inc.; Spectaire Holdings, Inc.; Centogene N.V.; DZS Inc.; Corner Growth Acquisition Corp. 2; Collective Audience, Inc.; Grom ...535NEW YORK, Oct. 10, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of Gamer Pakistan Inc. Gamer Pakistan Inc.'s securities were suspended on...
► Artikel lesen
25.09.24Centogene NV: CENTOGENE Data on Novel Genetic Risk Factor for Parkinson's Disease in The Lancet Neurology496Rostock International Parkinson's Disease (ROPAD) Study demonstrates a significant link between the RAB32 gene variant and Parkinson's disease, further supporting recent findingsData from over subcohort...
► Artikel lesen
20.08.24XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 20.08.20241.023The following instruments on Boerse Frankfurt do have their last trading day on 20.08.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 20.08.2024ISIN NameNL0014040206 CENTOGENE...
► Artikel lesen
08.08.24Centogene NV: CENTOGENE Receives Delisting Notice From Nasdaq506CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Centogene N.V., the essential life science partner for data-driven answers in rare and neurodegenerative diseases...
► Artikel lesen
01.08.24Centogene NV: CENTOGENE Publication in Brain Journal Reveals 15% of Parkinson's Disease Cases Are Linked to Genetic Factors319Initial data from largest international Parkinson's disease patient cohort shows approximately 90% of these genetically confirmed patients had variants in the LRRK2 or GBA1 genes, making these individuals...
► Artikel lesen
11 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1